Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide vs Metolazone in ADHF
NCT06414759Phase 4Recruiting
- Sponsor
- Cairo University
- Start
- Jul 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetazolamide, metolazone in heart failure (HF), Volume overload, sponsored by Cairo University. Started Jul 2024; status: recruiting.
02
Drugs
acetazolamidemetolazone
03
Conditions
heart failure (HF)Volume overload
Beyond the preview
Go deeper on NCT06414759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06414759.